Human Genome Sciences Notae | Tabula navigationisHUMAN GENOME SCIENCES ANNOUNCES 2008 GOALS AND REPORTS SUBSTANTIAL PROGRESS TOWARD COMMERCIALIZATION AT JPMORGAN HEALTHCARE CONFERENCE
MedicamentaBiotechnologiaSocietatesConstituta 1992
sodalitasbiopharmaceutica1992DNAproteinianticorporisqueHepatitis CLupus erythematodesAnthraxcancerarthritis rheumatoidisVIDHSIDA
Human Genome Sciences (Anglice; Latine: Scientiae Genomatis Humanae) est sodalitas biopharmaceutica anno 1992 fundata. Ordinem DNA humani utitur ut medicamenta proteini anticorporisque crearet. Ab anno 2008, medicamentis operam dat ad sanandum Hepatitis C, Lupus erythematodes, Anthrax, cancer, arthritis rheumatoidis, et VIDH/SIDA. Adiutor est cum aliis sodalitatibus biotechnologicis pharmaceuticisque ad progressum et pactiones technologicas.[1]
Notae |
↑ HUMAN GENOME SCIENCES ANNOUNCES 2008 GOALS AND REPORTS SUBSTANTIAL PROGRESS TOWARD COMMERCIALIZATION AT JPMORGAN HEALTHCARE CONFERENCE, HGS Press Release, January 7, 2008